GE HealthCare partners with BAMF Health to propel theranostics adoption, amplifying precision medicine in the U.S. This alliance harnesses cutting-edge imaging technology and therapeutic agents to target cancer cells precisely. The collaboration spans technology…
Continue Reading
GE HealthCare announced a collaboration with Grand Rapids-based cancer treatment center BAMF Health to advance the adoption of theranostics in the U.S. Theranostics is an emerging technology and a form of precision medicine that fuses…
Continue Reading
Elekta, a global leader in brachytherapy solutions, has acquired iCAD, Inc.’s Xoft business, including the innovative Xoft Axxent Electronic Brachytherapy (eBx) System. This technology, utilizing a miniaturized X-ray source, offers precise cancer treatment with…
Continue Reading
Elekta has won a tender to supply several Harmony linear accelerators (linacs) to Ukraine, aiming to alleviate the country’s cancer treatment shortage. These modern radiation therapy devices will be operational by 2024, enhancing cancer…
Continue Reading
Cleveland Clinic and IBM have secured $40 million in funding from the Wellcome Trust to lead quantum computing projects for healthcare applications. The initiative, part of the Wellcome Leap Quantum for Bio Challenge, aims…
Continue Reading
What You Should Know:
– Georgiamune, a privately held, clinical stage biotechnology company, and Verily, an Alphabet precision health technology company forms a strategic partnership to advance novel therapeutics for patients with cancer.
– Through this…
Continue Reading
What You Should Know: Pangea Biomed, the startup behind the innovative treatment response predictor, ENLIGHT, today announced its partnership with patient-centric advocacy organization FibroFighters to advance treatment for fibrolamellar carcinoma (FLC) patients.Fibrolamellar carcinoma (FLC)…
Continue Reading
Radionetics Oncology has initiated a Phase 1 clinical trial for 68Ga-R8760, a pioneering radioligand imaging agent designed to detect adrenocortical carcinoma. The study, R8760-101 (NCT05999292), focuses on assessing the agent’s safety and dosimetry. Dr….
Continue Reading
In the relentless global battle against cancer, generative artificial intelligence (Gen AI) has emerged as a powerful tool in oncology’s arsenal. With the capacity to analyse vast datasets, simulate complex molecular interactions, and tailor…
Continue Reading
New research conducted by radiation oncology physicists at Miami Cancer Institute reveals remarkable precision in intracranial stereotactic radiosurgery (SRS) using an MR-guided radiotherapy system, the ViewRay MRIdian. Published in the International Journal of Radiation…
Continue Reading
